Tumor‐ and Drug‐Induced Cutaneous Neuro‐Phospholipidosis
Identifieur interne : 003A29 ( Main/Exploration ); précédent : 003A28; suivant : 003A30Tumor‐ and Drug‐Induced Cutaneous Neuro‐Phospholipidosis
Auteurs : C. E. Orfanos [Allemagne] ; U. Runne [Allemagne]Source :
- Journal of Cutaneous Pathology [ 0303-6987 ] ; 1975-10.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Analgésiques (effets indésirables), Analgésiques (usage thérapeutique), Axones (ultrastructure), Carcinome bronchogénique (), Carcinome bronchogénique (anatomopathologie), Chloroquine (effets indésirables), Chloroquine (usage thérapeutique), Ergotamine (effets indésirables), Ergotamine (usage thérapeutique), Femelle, Humains, Lipidoses (), Lipidoses (étiologie), Mâle, Mélanome (anatomopathologie), Métastase tumorale, Neuropathies périphériques (), Neuropathies périphériques (étiologie), Peau (innervation), Phospholipides (métabolisme), Sujet âgé, Tumeurs cutanées (), Tumeurs cutanées (anatomopathologie), Tumeurs du poumon (), Tumeurs du poumon (anatomopathologie).
- MESH :
- anatomopathologie : Carcinome bronchogénique, Mélanome, Tumeurs cutanées, Tumeurs du poumon.
- effets indésirables : Analgésiques, Chloroquine, Ergotamine.
- métabolisme : Peau, Phospholipides.
- usage thérapeutique : Analgésiques, Axones, Chloroquine, Ergotamine.
- étiologie : Lipidoses, Neuropathies périphériques.
- Adulte, Adulte d'âge moyen, Carcinome bronchogénique, Femelle, Humains, Lipidoses, Mâle, Métastase tumorale, Neuropathies périphériques, Sujet âgé, Tumeurs cutanées, Tumeurs du poumon.
English descriptors
- KwdEn :
- Adult, Aged, Analgesics (adverse effects), Analgesics (therapeutic use), Axons (ultrastructure), Carcinoma, Bronchogenic (complications), Carcinoma, Bronchogenic (pathology), Chloroquine (adverse effects), Chloroquine (therapeutic use), Ergotamine (adverse effects), Ergotamine (therapeutic use), Female, Humans, Lipidoses (chemically induced), Lipidoses (etiology), Lung Neoplasms (complications), Lung Neoplasms (pathology), Male, Melanoma (pathology), Middle Aged, Neoplasm Metastasis, Peripheral Nervous System Diseases (chemically induced), Peripheral Nervous System Diseases (etiology), Phospholipids (metabolism), Skin (innervation), Skin Neoplasms (complications), Skin Neoplasms (pathology).
- MESH :
- chemical , adverse effects : Analgesics, Chloroquine, Ergotamine.
- chemical , metabolism : Phospholipids.
- chemical , therapeutic use : Analgesics, Chloroquine, Ergotamine.
- chemically induced : Lipidoses, Peripheral Nervous System Diseases.
- complications : Carcinoma, Bronchogenic, Lung Neoplasms, Skin Neoplasms.
- etiology : Lipidoses, Peripheral Nervous System Diseases.
- innervation : Skin.
- pathology : Carcinoma, Bronchogenic, Lung Neoplasms, Melanoma, Skin Neoplasms.
- ultrastructure : Axons.
- Teeft :
- Abraham hendy, Adult, Aged, Axon, Axonal, Barbituric acid, Brain gangliosides, Bronchogenic carcinoma, Carcinoma, Carcinomatous, Carcinomatous neuropathy, Chloroquine, Chronic abuse, Cutaneous, Cutaneous axons, Drug history, Electron microscope, Female, Hereditary disorders, Humans, Jottrnal, Lipid, Lipid storage, Male, Middle Aged, Neoplasm Metastasis, Neuromyopathy, Neuropathy, Orfanos, Peripheral neuromyopathy, Runne, Schwann cells.
Abstract
Drugs and metastatic malignant tumors may induce severe alterations in cutaneous axons. The most prominent ultrastructural feature of axonal dystrophy of this type was the presence of multiple lamellated osmiophilic bodies (LOB), similar to those occurring in hereditary disorders with increase of brain gangliosides and lipid storage. Chloroquine, ergotamine, ethaverine and chronic abuse of non‐narcotic analgesic drugs seem to be responsible for the drug‐induced cutaneous neuro‐phospholipidosis, whereas the same condition was found in two patients with metastatic bronchogenic carcinoma and malignant melanoma.
Url:
DOI: 10.1111/j.1600-0560.1975.tb00171.x
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 000590
- to stream Istex, to step Curation: 000590
- to stream Istex, to step Checkpoint: 002776
- to stream PubMed, to step Corpus: 000632
- to stream PubMed, to step Curation: 000632
- to stream PubMed, to step Checkpoint: 000599
- to stream Ncbi, to step Merge: 000102
- to stream Ncbi, to step Curation: 000102
- to stream Ncbi, to step Checkpoint: 000102
- to stream Main, to step Merge: 003B09
- to stream Main, to step Curation: 003A29
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Tumor‐ and Drug‐Induced Cutaneous Neuro‐Phospholipidosis</title>
<author><name sortKey="Orfanos, C E" sort="Orfanos, C E" uniqKey="Orfanos C" first="C. E." last="Orfanos">C. E. Orfanos</name>
</author>
<author><name sortKey="Runne, U" sort="Runne, U" uniqKey="Runne U" first="U." last="Runne">U. Runne</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:0CB9F6230B9CA009395D699CED966AC15B294C71</idno>
<date when="1975" year="1975">1975</date>
<idno type="doi">10.1111/j.1600-0560.1975.tb00171.x</idno>
<idno type="url">https://api.istex.fr/ark:/67375/WNG-ZPNF9GK3-9/fulltext.pdf</idno>
<idno type="wicri:Area/Istex/Corpus">000590</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Corpus" wicri:corpus="ISTEX">000590</idno>
<idno type="wicri:Area/Istex/Curation">000590</idno>
<idno type="wicri:Area/Istex/Checkpoint">002776</idno>
<idno type="wicri:explorRef" wicri:stream="Istex" wicri:step="Checkpoint">002776</idno>
<idno type="wicri:doubleKey">0303-6987:1975:Orfanos C:tumor:and:drug</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:175101</idno>
<idno type="wicri:Area/PubMed/Corpus">000632</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000632</idno>
<idno type="wicri:Area/PubMed/Curation">000632</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000632</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000599</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000599</idno>
<idno type="wicri:Area/Ncbi/Merge">000102</idno>
<idno type="wicri:Area/Ncbi/Curation">000102</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000102</idno>
<idno type="wicri:doubleKey">0303-6987:1975:Orfanos C:tumor:and:drug</idno>
<idno type="wicri:Area/Main/Merge">003B09</idno>
<idno type="wicri:Area/Main/Curation">003A29</idno>
<idno type="wicri:Area/Main/Exploration">003A29</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title level="a" type="main">Tumor‐ and Drug‐Induced Cutaneous Neuro‐Phospholipidosis</title>
<author><name sortKey="Orfanos, C E" sort="Orfanos, C E" uniqKey="Orfanos C" first="C. E." last="Orfanos">C. E. Orfanos</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Dermatology, University of Cologne</wicri:regionArea>
<wicri:noRegion>University of Cologne</wicri:noRegion>
<wicri:noRegion>University of Cologne</wicri:noRegion>
</affiliation>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Correspondence address: Professor Dr. C. E. Orfanos, Dr. U. Runne, University Skin Hospital, 5 Cologne, Joseph‐Steltzmann‐Str. 9</wicri:regionArea>
<wicri:noRegion>Joseph‐Steltzmann‐Str. 9</wicri:noRegion>
<wicri:noRegion>Joseph‐Steltzmann‐Str. 9</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Runne, U" sort="Runne, U" uniqKey="Runne U" first="U." last="Runne">U. Runne</name>
<affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Dermatology, University of Cologne</wicri:regionArea>
<wicri:noRegion>University of Cologne</wicri:noRegion>
<wicri:noRegion>University of Cologne</wicri:noRegion>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series><title level="j" type="main">Journal of Cutaneous Pathology</title>
<title level="j" type="alt">JOURNAL OF CUTANEOUS PATHOLOGY</title>
<idno type="ISSN">0303-6987</idno>
<idno type="eISSN">1600-0560</idno>
<imprint><biblScope unit="vol">2</biblScope>
<biblScope unit="issue">5</biblScope>
<biblScope unit="page" from="232">232</biblScope>
<biblScope unit="page" to="239">239</biblScope>
<biblScope unit="page-count">8</biblScope>
<publisher>Blackwell Publishing Ltd</publisher>
<pubPlace>Oxford, UK</pubPlace>
<date type="published" when="1975-10">1975-10</date>
</imprint>
<idno type="ISSN">0303-6987</idno>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><idno type="ISSN">0303-6987</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Aged</term>
<term>Analgesics (adverse effects)</term>
<term>Analgesics (therapeutic use)</term>
<term>Axons (ultrastructure)</term>
<term>Carcinoma, Bronchogenic (complications)</term>
<term>Carcinoma, Bronchogenic (pathology)</term>
<term>Chloroquine (adverse effects)</term>
<term>Chloroquine (therapeutic use)</term>
<term>Ergotamine (adverse effects)</term>
<term>Ergotamine (therapeutic use)</term>
<term>Female</term>
<term>Humans</term>
<term>Lipidoses (chemically induced)</term>
<term>Lipidoses (etiology)</term>
<term>Lung Neoplasms (complications)</term>
<term>Lung Neoplasms (pathology)</term>
<term>Male</term>
<term>Melanoma (pathology)</term>
<term>Middle Aged</term>
<term>Neoplasm Metastasis</term>
<term>Peripheral Nervous System Diseases (chemically induced)</term>
<term>Peripheral Nervous System Diseases (etiology)</term>
<term>Phospholipids (metabolism)</term>
<term>Skin (innervation)</term>
<term>Skin Neoplasms (complications)</term>
<term>Skin Neoplasms (pathology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Analgésiques (effets indésirables)</term>
<term>Analgésiques (usage thérapeutique)</term>
<term>Axones (ultrastructure)</term>
<term>Carcinome bronchogénique ()</term>
<term>Carcinome bronchogénique (anatomopathologie)</term>
<term>Chloroquine (effets indésirables)</term>
<term>Chloroquine (usage thérapeutique)</term>
<term>Ergotamine (effets indésirables)</term>
<term>Ergotamine (usage thérapeutique)</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lipidoses ()</term>
<term>Lipidoses (étiologie)</term>
<term>Mâle</term>
<term>Mélanome (anatomopathologie)</term>
<term>Métastase tumorale</term>
<term>Neuropathies périphériques ()</term>
<term>Neuropathies périphériques (étiologie)</term>
<term>Peau (innervation)</term>
<term>Phospholipides (métabolisme)</term>
<term>Sujet âgé</term>
<term>Tumeurs cutanées ()</term>
<term>Tumeurs cutanées (anatomopathologie)</term>
<term>Tumeurs du poumon ()</term>
<term>Tumeurs du poumon (anatomopathologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Analgesics</term>
<term>Chloroquine</term>
<term>Ergotamine</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Phospholipids</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Analgesics</term>
<term>Chloroquine</term>
<term>Ergotamine</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Carcinome bronchogénique</term>
<term>Mélanome</term>
<term>Tumeurs cutanées</term>
<term>Tumeurs du poumon</term>
</keywords>
<keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Lipidoses</term>
<term>Peripheral Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Carcinoma, Bronchogenic</term>
<term>Lung Neoplasms</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Analgésiques</term>
<term>Chloroquine</term>
<term>Ergotamine</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Lipidoses</term>
<term>Peripheral Nervous System Diseases</term>
</keywords>
<keywords scheme="MESH" qualifier="innervation" xml:lang="en"><term>Skin</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Peau</term>
<term>Phospholipides</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Carcinoma, Bronchogenic</term>
<term>Lung Neoplasms</term>
<term>Melanoma</term>
<term>Skin Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="ultrastructure" xml:lang="en"><term>Axons</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Analgésiques</term>
<term>Axones</term>
<term>Chloroquine</term>
<term>Ergotamine</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Lipidoses</term>
<term>Neuropathies périphériques</term>
</keywords>
<keywords scheme="Teeft" xml:lang="en"><term>Abraham hendy</term>
<term>Adult</term>
<term>Aged</term>
<term>Axon</term>
<term>Axonal</term>
<term>Barbituric acid</term>
<term>Brain gangliosides</term>
<term>Bronchogenic carcinoma</term>
<term>Carcinoma</term>
<term>Carcinomatous</term>
<term>Carcinomatous neuropathy</term>
<term>Chloroquine</term>
<term>Chronic abuse</term>
<term>Cutaneous</term>
<term>Cutaneous axons</term>
<term>Drug history</term>
<term>Electron microscope</term>
<term>Female</term>
<term>Hereditary disorders</term>
<term>Humans</term>
<term>Jottrnal</term>
<term>Lipid</term>
<term>Lipid storage</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Neoplasm Metastasis</term>
<term>Neuromyopathy</term>
<term>Neuropathy</term>
<term>Orfanos</term>
<term>Peripheral neuromyopathy</term>
<term>Runne</term>
<term>Schwann cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Carcinome bronchogénique</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lipidoses</term>
<term>Mâle</term>
<term>Métastase tumorale</term>
<term>Neuropathies périphériques</term>
<term>Sujet âgé</term>
<term>Tumeurs cutanées</term>
<term>Tumeurs du poumon</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Drugs and metastatic malignant tumors may induce severe alterations in cutaneous axons. The most prominent ultrastructural feature of axonal dystrophy of this type was the presence of multiple lamellated osmiophilic bodies (LOB), similar to those occurring in hereditary disorders with increase of brain gangliosides and lipid storage. Chloroquine, ergotamine, ethaverine and chronic abuse of non‐narcotic analgesic drugs seem to be responsible for the drug‐induced cutaneous neuro‐phospholipidosis, whereas the same condition was found in two patients with metastatic bronchogenic carcinoma and malignant melanoma.</div>
</front>
</TEI>
<affiliations><list><country><li>Allemagne</li>
</country>
</list>
<tree><country name="Allemagne"><noRegion><name sortKey="Orfanos, C E" sort="Orfanos, C E" uniqKey="Orfanos C" first="C. E." last="Orfanos">C. E. Orfanos</name>
</noRegion>
<name sortKey="Orfanos, C E" sort="Orfanos, C E" uniqKey="Orfanos C" first="C. E." last="Orfanos">C. E. Orfanos</name>
<name sortKey="Runne, U" sort="Runne, U" uniqKey="Runne U" first="U." last="Runne">U. Runne</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/ChloroquineV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A29 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003A29 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= ChloroquineV1 |flux= Main |étape= Exploration |type= RBID |clé= ISTEX:0CB9F6230B9CA009395D699CED966AC15B294C71 |texte= Tumor‐ and Drug‐Induced Cutaneous Neuro‐Phospholipidosis }}
This area was generated with Dilib version V0.6.33. |